Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02301247 · ClinicalTrials.gov registry record · NA
Treating New Learning and Memory Deficits in Progressive Multiple Sclerosis (MS)
A NA study, sponsored by Kessler Foundation.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02301247 is a NA study that has completed, run by Kessler Foundation. The registered enrollment target is 32 participants.
The verdict
NCT02301247, a NA study, has completed, sponsored by Kessler Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This study is a double-blind placebo-controlled randomized clinical trial (RCT) to provide Class I evidence in support of or in refute of the efficacy of the modified Story Memory Technique (mSMT) in persons with progressive MS, with outcome measured through three mechanisms: (1) a traditional neuropsychological evaluation (NPE) (2) an assessment of global functioning (AGF) examining the impact of the treatment on daily activities, and (3) an optional functional magnetic resonance imaging (fMRI) scan.
Interventions
- BEHAVIORAL Memory retraining exercises
- BEHAVIORAL Placebo control memory exercises
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2014-11 |
| Est. Completion | 2017-04-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02301247
The ClinicalTrials.gov registry entry for NCT02301247 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Memory retraining exercises is the first listed.
NCT02301247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02301247 about?
NCT02301247 is a clinical study titled "Treating New Learning and Memory Deficits in Progressive Multiple Sclerosis (MS)". This study is a double-blind placebo-controlled randomized clinical trial (RCT) to provide Class I evidence in support of or in refute of the efficacy of the modified Story Memory Technique (mSMT) in persons with progressive MS, with outcome measured through three mechanisms: (1) a traditional neuro...
What is the current status of trial NCT02301247?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2014-11. Estimated completion is 2017-04-02.
What interventions are being tested in trial NCT02301247?
The interventions under investigation include: Memory retraining exercises (BEHAVIORAL), Placebo control memory exercises (BEHAVIORAL).
Who is sponsoring clinical trial NCT02301247?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.